Preparation method of nanometer targeted drug, and application of nanometer targeted drug for treating gastric carcinoma
A nano-drug, targeting technology, applied in the field of biomedicine, to achieve the effects of good application prospects, high emission quantum yield, and excellent sustained release
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0111] Embodiment 1, the preparation of nano therapeutic drug
[0112] Two kinds of nano-therapeutic drugs were prepared respectively. Both nanotherapeutics have the same linker: cysteine, the targeting ligand is transferrin, and the chemotherapy drug is doxorubicin, but the nanocarriers are different. Gold nanoparticles (GNPs) were used in the first nanotherapeutic drug due to their unique physical properties, and zinc sulfide quantum dots (ZnS) were selected as the second nanotherapeutic drug nanocarrier.
[0113] The preparation of nano therapeutic drug is as follows:
[0114] 1. The preparation of GNP nano-therapeutic drugs, including the synthesis of GNP, the combination of cysteine and GNP, the combination of doxorubicin and GNP-Cys, and the combination of transferrin and GNP-Cys-Dox.
[0115] GNPs were synthesized using an optimized citric acid reduction method. Different concentrations of gold salts and sodium citrate were used to check the ideal concentration. GNP...
Embodiment 2
[0123] Example 2, Preparation and Characterization of Diagnostic Probes
[0124] Synthetic cysteine-coated GNPs were conjugated to transferrin for diagnostic probing. It is used to examine the efficiency of transferrin as a targeting ligand for cancer and liver cancer cells. Expression of transferrin in induced gastric cancer tissues was also examined.
[0125] Such as figure 1 Shown in (b), is the UV-Vis spectrum analysis of the target diagnostic probe, which is compared with the UV-Vis spectrum of cysteine-coated GNP, as figure 1 (a) shown. The spectrum of cysteine-coated GNPs showed a sharp peak at 520nm, indicating a narrow size distribution with a particle size of less than 20nm. After transferrin binding, as figure 1 As shown in (b), the new spectrum shows a shift of the inorganic peak at 525 nm from the organic peak at 340 nm. The peaks became broader, indicating that conjugation of the protein on the nanoparticles resulted in an increase in the size of the nanoco...
Embodiment 3
[0131] Example 3, Therapeutic Effects of GNP and ZnS QDs
[0132] 1. Nanomedicine for GNP tumor therapy (in vitro)
[0133] Cellular uptake, therapeutic efficacy and cellular targeting of a therapeutic nanomedicine against colon cancer cell (HCT 116-Luc2 and confirmed by different analyses. Techniques used to study cell viability for intracellular nanomedicine tracking include inverted microscopy, fluorescence microscopy, trypan blue assay, neutral red assay (metabolic activity), crystal violet staining assay (cell adhesion studies), and fluorescence intensity measurements. Statistical comparison of all results leads to clear results.
[0134] Human colon cancer cell line: HCT-116 (a male patient-derived cell line) was used to examine the effect of therapeutic nanomedicines in vitro. Involved cell lines specify a mismatch-deficient repair system for p53 wild-type and K-Ras mutants. The morphology of the cells is a spindle-shaped appearance. The reserved vials were remove...
PUM
Property | Measurement | Unit |
---|---|---|
Particle size | aaaaa | aaaaa |
The average diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com